Skip to main content

What the FDA labels say about taking them together

Mitomycin and palonosetron

Palonosetron's FDA label (Palonosetron Hydrochloride) of January 13, 2022 names mitomycin in its drug interactions section; the mitomycin labels PlainMeds reads (4) do not name palonosetron.

Check it at the source: the mitomycin FDA label on DailyMed (effective April 22, 2025, Accord Healthcare, Inc.); the palonosetron FDA label on DailyMed (effective April 29, 2025, Avyxa Pharma, LLC).

What does the mitomycin label say about palonosetron?

Mitomycin's label (effective April 22, 2025) and its 3 other brand-application labels do not name palonosetron in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Mitomycin), Accord Healthcare, Inc., effective April 22, 2025 (SPL set ff676355-313d-4575-8f2f-e4a1e9527477), via openFDA; the full label on DailyMed

What does the palonosetron label say about mitomycin?

Palonosetron Hydrochloride label (Cipla USA Inc., January 13, 2022), drug interactions

Palonosetron did not inhibit the antitumor activity of the five chemotherapeutic agents tested (cisplatin, cyclophosphamide, cytarabine, doxorubicin and mitomycin C) in murine tumor models.

Source: FDA drug label (Palonosetron Hydrochloride, NDA021372), Cipla USA Inc., effective January 13, 2022 (SPL set 37e7ef89-fd77-44e0-9271-ae91f8822603), via openFDA

Source: FDA drug label (posfrea), Avyxa Pharma, LLC, effective April 29, 2025 (SPL set 13a201ba-c86d-48c5-a0e1-a3e0b4e6a2a7), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

11Mitomycin generic labelers
13Palonosetron generic labelers
MitomycinPalonosetron
Labeled forGlaucomaNausea and vomiting
Boxed warningYesNo
Pharmacy cost (NADAC)n/an/a
Shortage nowNo current entryA presentation being discontinued

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?